Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review-Reference-Cited by-同舟云学术

Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review

Published:2015 Issue:6 Volume:21 Page:1945
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Broder Michael S

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference24 articles.

1. NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

2. Systemic Treatment in Unresectable Metastatic Well-Differentiated Carcinoid Tumors

3. Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

4. Sandostatin LAR Depot [prescribing information]. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2011. Accessed 7/30/14. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.

5. DistillerSR (Version 2.0). (2012) Ottawa, Ontario, Canada: Evidence Partners Incorporated. Available from: http://systematic-review.net.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin analogues as a treatment option for cystoid maculopathy in retinitis pigmentosa;BMJ Open Ophthalmology;2024-08

2. Multimodal management of foregut neuroendocrine neoplasms;Best Practice & Research Clinical Gastroenterology;2024-02

3. From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2024-01

4. Small Intestinal, Colorectal, and Appendicular Neuroendocrine Tumors;Neuroendocrine Tumours;2024

5. Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center;Cancers;2023-11-18